title: What clinical factors are associated with biphasic anaphylaxis in Thai adult patients?
abstract: BACKGROUND
  Anaphylaxis is an emergency condition and may be fatal. Approximately 20% of patients with anaphylaxis may develop recurrent episodes of anaphylaxis within 72 hours or biphasic anaphylaxis. The severity of biphasic anaphylaxis can be either more or less severe than the first episode. Knowledge of factors associated with biphasic anaphylaxis in particular in Asian populations is still limited.
  
  
  OBJECTIVE
  To study predictors for biphasic anaphylaxis in Thai patients at the Emergency Department (ED).
  
  
  METHODS
  All consecutive patients diagnosed as anaphylaxis at the ED, Ramathibodi Hospital, Mahidol University, Bangkok were enrolled. The study was prospectively conducted from January to December 2011. Patients were divided into two groups; uniphasic and biphasic anaphylaxis. Multivariate logistic regression was used to identify factors associated with biphasic anaphylaxis.
  
  
  RESULTS
  During the study period, there were 63 patients diagnosed with anaphylaxis at the ED. Of those, 16 patients were excluded due to or treatment of anaphylaxis, concomitant medications or pre hospital treatment. In total, there were 47 patients remaining in the study, including 10 patients with biphasic anaphylaxis (21.28%). The clinical characteristics of the uniphasic and biphasic anaphylaxis groups were comparable. In multivariate logistic regression analyses, only respiratory rate and abdominal pain were significantly associated with biphasic anaphylaxis. The adjusted ORs (95% CI) of both factors were 0.653 (0.457, 0.932) and 15.429 (1.395, 170.690), respectively.
  
  
  CONCLUSIONS
  Reduced respiratory rate and the presence of abdominal pain were two significant factors associated with biphasic anaphylaxis.
authors.affiliation: Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.
authors.forename: Pungkava
authors.initials: P
authors.lastname: Sricharoen
authors.forename: Yuwares
authors.initials: Y
authors.lastname: Sittichanbuncha
authors.forename: Arrug
authors.initials: A
authors.lastname: Wibulpolprasert
authors.forename: Ekkapong
authors.initials: E
authors.lastname: Srabongkosh
authors.forename: Kittisak
authors.initials: K
authors.lastname: Sawanyawisuth
mesh_terms: D015746:Abdominal Pain / Q000503:physiopathology*; D000328:Adult; D000485:Allergens; D000707:Anaphylaxis / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D000799:Angioedema / Q000503:physiopathology; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D004417:Dyspnea / Q000503:physiopathology; D005076:Exanthema / Q000503:physiopathology; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009325:Nausea / Q000503:physiopathology; D011446:Prospective Studies; D056152:Respiratory Rate; D012720:Severity of Illness Index; D013785:Thailand
chemical_list: D000485:Allergens; D018927:Anti-Asthmatic Agents